Urolon clinical trial: 6-month interim data available

07 March 2018

The AQLANE Medical™ European Clinical Trial continues to make progress as subjects reach their 12-month follow-up!

In January 2018 an analysis of the 6-month interim data show Urolon™ as a safe and effective treatment option for females with mild to moderate stress urinary incontinence (SUI) who have attempted or failed pelvic floor muscle training (PFMT). We are delighted with this data (available on request) and look forward to seeing the 12-month data on all subjects, available in June 2018!